Identification and clinical implications of immune-related hub genes in psoriasis
PLOS One · 20.04.2026 · 21 (4) · e0347536
DOI: 10.1371/journal.pone.0347536 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 20.04.2026. Verfasst von Yuzhen Sun und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The First People's Hospital of Zhengzhou, Zhengzhou, Henan, China. Hauptthemen laut MEDLINE: Psoriasis, Gene Regulatory Networks. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Psoriasis, a chronic inflammatory skin disease affecting 2–3% of the global population, is driven by dysregulated immune responses. Despite advancements in biologic therapies, treatment challenges persist due to high recurrence rates. This study aimed to identify immune-related hub genes and elucidate their clinical implications in psoriasis pathogenesis and therapy.
Methods
Multiple microarray datasets from psoriasis patients (GSE30999, GSE106992, GSE14905, GSE78097, and GSE117468) were obtained to identify immune-key genes by differential gene analysis and Weighted Gene Co-expression Network Analysis (WGCNA). Subsequently, immune-related hub genes were identified using the Least Absolute Shrinkage and Selection Operator (LASSO) algorithm and Protein-Protein Interaction (PPI) networks, with further validation through Gene Set Enrichment Analysis (GSEA) and Receiver Operating Characteristic (ROC) curves to assess exploratory within-sample discrimination. Pearson correlation analysis evaluated the relationship between hub genes, skin lesion severity, and treatment outcomes. The study also conducted immune infiltration by using the Cell-type Identification by Estimating Relative Subsets Of RNA Transcripts (CIBERSORT) algorithm and identified potential therapeutic targets by the Drug-Gene Interaction Database (DGIdb).
Results
Thirty-one immune-related key genes were identified, and six hub genes ( CLEC7A, CXCL1, IRF1, S100A12, S100A8, S100A9 ) were validated as central players in immune signaling pathways. These genes exhibited within-sample discrimination (AUC > 0.9) and correlated with disease severity and biological therapy efficacy. Immune infiltration analysis revealed increased activated memory CD4 + T cells and M1 macrophages in lesional skin, which was strongly associated with hub gene expression. Additionally, drug-gene interaction analysis identified potential therapeutic agents targeting these genes.
Conclusion
This study identified six immune-related hub genes that were closely linked to the severity of psoriasis, the effectiveness of biological treatments, and infiltrated activated memory CD4 + T cells and M1 macrophages. Our findings elucidate a novel immune-related hub gene network in psoriasis and provide potential targets for the development and application of biologics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, The First People's Hospital of Zhengzhou, Zhengzhou, Henan, China.
- Department of Pulmonary and Critical Care Medicine, Huashan Hospital of Fudan University, Shanghai, China.
ORCID-Profile: Weiyuan Fang
Zitieren
APA
Sun, Y., Zhou, Z., Mao, Y., Liu, N., Li, Y., & Fang, W. (2026). Identification and clinical implications of immune-related hub genes in psoriasis. PLOS One, 21(4), e0347536. https://doi.org/10.1371/journal.pone.0347536
Vancouver
Sun Y, Zhou Z, Mao Y, Liu N, Li Y, Fang W. Identification and clinical implications of immune-related hub genes in psoriasis. PLOS One. 2026;21(4):e0347536. doi:10.1371/journal.pone.0347536
BibTeX
@article{Sun2026,
author = {Sun, Yuzhen and Zhou, Ziguang and Mao, Yu and Liu, Niu and Li, Yanfeng and Fang, Weiyuan},
title = {Identification and clinical implications of immune-related hub genes in psoriasis},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {4},
pages = {e0347536},
doi = {10.1371/journal.pone.0347536}
}
EUVIMED